InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,431.60
(
-0.04%
)
US TECH 100
19,166.40
(
0.51%
)
Dow Jones
38,589.16
(
-0.15%
)
Brent Oil
82.28
(
0.00%
)
Bitcoin
66,211.58
(
0.31%
)
Post# of 20617
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Keepinitsimple

Send PM Follow Ignore
Followers 7
Posts 467
Boards Moderated 0
Alias Born 08/09/2016

Keepinitsimple

Re: None

Friday, 03/17/2017 11:52:04 AM

Friday, March 17, 2017 11:52:04 AM

Post# of 20617
This is the reply I got from Kevin at IR yesterday as I was interested in getting their perspective still. I asked how you see today's news being beneficial to the shareholder. Response below:


Hopefully they have a strategy to put this funding to use quickly to grow profitability, but I agree it seems as if it was done on unfavorable terms (at least near term). It also may give them more visibility and coverage.

Kevin Holmes
Chesapeake Group
410-825-3930


These materials are provided for information purposes only. This is not a solicitation to buy or sell securities. Chesapeake has been paid a fee to provide investor relations services for Innovus Pharmaceuticals, Inc.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up